High dose of IV iron ‘optimal’ for pregnant women with deficiency
Australian research suggests a 1000mg dose is the most efficient approach and has no adverse impact
Pregnant women with intractable iron deficiency fare better if treated with 1000mg IV iron dose, requiring fewer repeat infusions than those given half that amount, a study finds.
The randomised controlled trial found a single 1000mg dose of ferric carboxymaltose may be optimal as women in the study arm receiving a dose of 500mg were twice as likely to require repeat infusions both pre- and postpartum, researchers say.
